Ramis Cabrer, Daniel (Date of defense: 2019-07-11)
Se ha establecido que un subconjunto de pacientes con cáncer debuta con infiltrados inmunes que se organizan en agregados en el nicho tumoral y sus alrededores. Estas estructuras linfoides se desarrollan ...
Mateu Jiménez, Mercè (Date of defense: 2017-12-18)
Chronic respiratory diseases, especially chronic obstructive pulmonary disease (COPD), and several molecular mechanisms may predispose to lung cancer (LC) development. Hypothesis: We hypothesized that ...
Puig Vilanova, Ester (Date of defense: 2014-07-16)
Skeletal muscle dysfunction and wasting are major comorbidities of chronic obstructive pulmonary disease (COPD) and lung cancer (LC). Despite that the lower limb muscles are usually more severely affected, ...
Chacón Cabrera, Alba (Date of defense: 2016-09-20)
Cachexia and muscle deconditioning, which are the major comorbidities in patients with chronic diseases including lung cancer (LC), impair disease prognosis. Several biological mechanisms are involved ...
Salazar Degracia, Anna (Date of defense: 2019-04-15)
La caquexia afecta negativamente a los pacientes con enfermedades crónicas y sobre todo en el cáncer. Las estrategias terapéuticas son aún limitadas. Los beta2-agonistas (formoterol) y el soporte ...
Fermoselle Pérez, Clara (Date of defense: 2012-11-26)
Muscle dysfunction and muscle wasting are major systemic manifestations of chronic conditions such as Chronic Obstructive Pulmonary Disease (COPD) and cancer. Several biological mechanisms contribute ...
Pascual, Sergi (Date of defense: 2015-11-17)
La inflamación y el estrés oxidativo son mecanismos moleculares que contribuyen al daño y a la disfunción muscular. Existen procesos crónicos con fenómenos inflamatorios de bajo grado pero de larga ...
Messaggi-Sartor, Monique (Date of defense: 2017-04-07)
Respiratory muscle dysfunction is a clinical condition that may be present in both respiratory and non-respiratory diseases. This impairment of muscle function can have a negative effect on clinical ...